Sophie Schmitz attended world orphan drug congress

Many rare disease patients lay their hope in gene-therapy development. However, recent experience with Glybera (uniQure) has shown difficulties faced in the launch and access. During the World Orphan Drug Congress in Washington this month, Partners4Access had the opportunity to get latest insights from a German sickness fund that reimbursed Glybera and the CEO of…

Partners4Access is pleased to announce the addition of Rosa Pandolfo to the London office

Continued focus is ‘Orphan Drug Solutions’ a partnership approach to ensuring a successful global launch. Partners4Access, the global access experts for orphan drugs, is pleased to announce that Rosa Pandolfo joined the company’s London Office as Senior Consultant. This addition helps further secure P4A’s position as the go-to partner for orphan drug manufacturers. Schmitz, Managing…